Association Between Adherence, A1C Improvement, and Type of Continuous Glucose Monitoring System in People with Type 1 Diabetes or Type 2 Diabetes Treated with Intensive Insulin Therapy-Reference-Cited by-同舟云学术

Association Between Adherence, A1C Improvement, and Type of Continuous Glucose Monitoring System in People with Type 1 Diabetes or Type 2 Diabetes Treated with Intensive Insulin Therapy

Published:2024-01-30 Issue:3 Volume:15 Page:639-648
ISSN:1869-6953
Container-title:Diabetes Therapy
language:en
Short-container-title:Diabetes Ther

Author:

Nemlekar Poorva M.^ORCID,Hannah Katia L.^ORCID,Green Courtney R.^ORCID,Norman Gregory J.^ORCID

Funder

Dexcom

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s13300-023-01529-8.pdf

Reference23 articles.

1. Friedman JG, Cardona Matos Z, Szmuilowicz ED, Aleppo G. Use of continuous glucose monitors to manage type 1 diabetes mellitus: progress, challenges, and recommendations. Pharmgenomics Pers Med. 2023;16:263–76. https://doi.org/10.2147/PGPM.S374663.

2. Sangave NA, Aungst TD, Patel DK. Smart connected insulin pens, caps, and attachments: a review of the future of diabetes technology. Diabetes Spectr. 2019;32(4):378–84. https://doi.org/10.2337/ds18-0069.

3. Beck RW, Riddlesworth T, Ruedy K, et al. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial. JAMA. 2017;317(4):371–8. https://doi.org/10.1001/jama.2016.19975.

4. Beck RW, Riddlesworth TD, Ruedy K, et al. Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial. Ann Intern Med. 2017;167(6):365–74. https://doi.org/10.7326/M16-2855.

5. Mustonen J, Rautiainen P, Lamidi ML, Lavikainen P, Martikainen J, Laatikainen T. Marked improvement in A1C levels after initiation of intermittently scanned continuous glucose monitoring is maintained over 4 years in patients with type 1 diabetes. Diabetes Spectr. 2022;35(4):469–75. https://doi.org/10.2337/ds21-0087.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of continuous glucose monitoring when initiating glucagon‐like peptide‐1 receptor agonist therapy in insulin‐treated diabetes;Diabetes, Obesity and Metabolism;2024-08-28

2. Blood glucose monitoring devices for type 1 diabetes: a journey from the food and drug administration approval to market availability;Frontiers in Endocrinology;2024-03-15